Arch Biopartners - Crunchbase Company Profile & Funding

Q: Where is Arch Biopartners's headquarters?

Arch Biopartners is located in Toronto, Ontario, Canada.

Q: Who invested in Arch Biopartners?

Arch Biopartners has 2 investors including National Research Council of Canada Industrial Research Assistance Program And Canadian Institutes of Health Research.

Q: When was the last funding round for Arch Biopartners?

Arch Biopartners closed its last funding round on obfuscated from a Post-IPO Equity round.

Q: How much funding has Arch Biopartners raised to date?

Arch Biopartners has raised obfuscated.

Overview

Arch Biopartners

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Arch Biopartners

CB Rank

68451

Arch Biopartners acquires and develops products and technology for sale to pharmaceutical and industrial companies.

Founded

obfuscation

Public

Post-IPO Equity

Toronto, Ontario, Canada

1-10

archbiopartners.com

Biopharma

Biotechnology

Medical

Funding Rounds

Post-IPO Equity

OBF

obfuscation

Post-IPO Equity

OBF

obfuscation

Post-IPO Equity

OBF

obfuscation

Key People

Paul Beck: Co-founder
Past Role: OpenX, Account Director, Strategic Accounts
Daniel Muruve: CSO

Details

Legal Name

Arch Biopartners, Inc.

Operating Status

Active

Stock Symbol

OTCPINK:ACHFF

Company Type

For Profit

Founders

Paul Beck, Richard Muruve

About the Company

Arch Biopartners Inc., a biotechnology company, focuses on acquiring and developing products and technology for sale to pharmaceutical and industrial companies. The company, through its subsidiaries, focuses on developing diagnosis and treatments for brain tumors; binding of peptides to solid surfaces; treatments for chronic kidney and bowel

diseases caused by non-infectious inflammation; and anti-cancer compounds. Arch Biopartners Inc. is headquartered in Toronto, Canada.

Phone Number

(647) 428–7031

Contact Email

info@archbiopartners.com

Predictions & Insights

Growth Insight

See this Growth Insight

Arch Biopartners is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Products & Services

LSALT peptide

A drug candidate targeting acute kidney injury (AKI) and organ inflammation by inhibiting the DPEP1 enzyme to prevent leukocyte recruitment and tissue injury.

Cilastatin

A repurposed drug candidate that inhibits DPEP1 to prevent toxin-related acute kidney injury by blocking toxin uptake in kidney tissue.

Research & Development

Arch Biopartners is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Post-IPO Equity - Arch Biopartners	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Arch Biopartners	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Arch Biopartners	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Arch Biopartners	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Arch Biopartners	—	obfuscated obfuscation	—	Post-IPO Equity

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Post-IPO Equity - Arch Biopartners	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Arch Biopartners	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Arch Biopartners	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Arch Biopartners	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Arch Biopartners	—	obfuscated obfuscation	—	Post-IPO Equity

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
National Research Council of Canada Industrial Research Assistance Program	Yes	Grant - Arch Biopartners	—
National Research Council of Canada Industrial Research Assistance Program	Yes	Grant - Arch Biopartners	—
National Research Council of Canada Industrial Research Assistance Program	Yes	Grant - Arch Biopartners	—
National Research Council of Canada Industrial Research Assistance Program	Yes	Grant - Arch Biopartners	—
National Research Council of Canada Industrial Research Assistance Program	Yes	Grant - Arch Biopartners	—